Impacts of the SOAT1 genetic variants and protein expression on HBV-related hepatocellular carcinoma

[1] Bray F(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424

[2] Ferlay J(2015)Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability Clin Liver Dis 19 223-238

[3] Soerjomataram I(2015)Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009 Hepatology 62 1723-1730

[4] Siegel RL(2015)Trends in Burden of Cirrhosis and Hepatocellular Carcinoma by Underlying Liver Disease in US Veterans, 2001–2013 Gastroenterology 149 1471-1482.e1475

[5] Torre LA(2001)Roles of acyl-coenzyme a:cholesterol acyltransferase-1 and -2 Curr Opin Lipidol 12 289-296

[6] Jemal A(2016)The role of cholesterol in the pathogenesis of NASH Trends Endocrinol Metab 27 84-95

[7] McGlynn KA(2001)Structure of the human acyl-CoA:cholesterol acyltransferase-2 (ACAT-2) gene and its relation to dyslipidemia Biochim Biophys Acta 1531 230-240

[8] Petrick JL(2005)Expression levels of ACAT1 and ACAT2 genes in the liver and intestine of baboons with high and low lipemic responses to dietary lipids J Nutr Biochem 16 714-721

[9] London WT(2000)Immunological quantitation and localization of ACAT-1 and ACAT-2 in human liver and small intestine J Biol Chem 275 28083-28092

[10] Younossi ZM(2000)ACAT1 and ACAT2 membrane topology segregates a serine residue essential for activity to opposite sides of the endoplasmic reticulum membrane Mol Biol Cell 11 3675-3687

[1] Bray F(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424

[2] Ferlay J(2015)Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability Clin Liver Dis 19 223-238

[3] Soerjomataram I(2015)Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009 Hepatology 62 1723-1730

[4] Siegel RL(2015)Trends in Burden of Cirrhosis and Hepatocellular Carcinoma by Underlying Liver Disease in US Veterans, 2001–2013 Gastroenterology 149 1471-1482.e1475

[5] Torre LA(2001)Roles of acyl-coenzyme a:cholesterol acyltransferase-1 and -2 Curr Opin Lipidol 12 289-296

[6] Jemal A(2016)The role of cholesterol in the pathogenesis of NASH Trends Endocrinol Metab 27 84-95

[7] McGlynn KA(2001)Structure of the human acyl-CoA:cholesterol acyltransferase-2 (ACAT-2) gene and its relation to dyslipidemia Biochim Biophys Acta 1531 230-240

[8] Petrick JL(2005)Expression levels of ACAT1 and ACAT2 genes in the liver and intestine of baboons with high and low lipemic responses to dietary lipids J Nutr Biochem 16 714-721

[9] London WT(2000)Immunological quantitation and localization of ACAT-1 and ACAT-2 in human liver and small intestine J Biol Chem 275 28083-28092

[10] Younossi ZM(2000)ACAT1 and ACAT2 membrane topology segregates a serine residue essential for activity to opposite sides of the endoplasmic reticulum membrane Mol Biol Cell 11 3675-3687